References
6. Angus D.C., Linde-Zwirble W.T., Lidicker J., Clermont G., Carcillo J., Pinsky M.R.. 2001;Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303–1310.
7. College of Korean Medicine Dermatology & Surgery Textbook Compilation Committee. 2007. Text of Traditional Korean Dermatology & Surgery Pusan: Sunwoo. p. 185–191.
8. Mang W.J.. 2015. Sanghanron Commentary Iksan: Wonkwang University Press Office. p. 190–198.
9. Byeon S.H., Hur S.C., Bye J.H., Jo G.M., Lee S.I.. 2018;Analysis of pharmacological studies on the purgation effect of Daeseunggi-tang. Herb Formula Sci 26(1):27–41.
https://doi.org/10.14374/HFS.2018.26.1.27
.
11. Koo B.S., Kim Y.S., Lee D.S., Moon S.K., Go C.N., Cho K.H., et al. 2000;Effects of Daeseungki-tang on constipated stroke patients. J Korean Med 20(2):3–13.
13. Liu D.. 2019. Liu Duzhou Sanghanron Lecture Paju: FishWood.
14. Hu X.. 2017. Hu Xishu GeumGweyoryak Lecture Paju: FishWood.
15. Evans L., Rhodes A., Alhazzani W., Antonelli M., Coopersmith C.M., French C., et al. 2021;Surviving sepsis campaign: International guidelines for management of sepsis and septic shock 2021. Intensive Care Med 47:1187–1247.
https://doi.org/10.1007/s00134-021-06506-y
.
16. Singer M., Deutschman C.S., Seymour C.W., Shankar-Hari M., Annane D., Bauer M., et al. 2016;The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315(8):801–810.
https://doi.org/10.1001/jama.2016.0287
.
17. Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Knaus W.A., et al. 1992;American college of chest physicians/society of critical care medicine consensus conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20(6):864–874.
https://doi.org/10.1378/chest.101.6.1644
.
19. Gamper G., Oschatz E., Herkner H., Paul G., Burgmann H., Janata K., et al. 2001;Sepsis-associated Purpura fulminans in adults. Wien Klin Wochenschr 113(3/4):107–112.
20. Gauer R., Forbes D., Boyer N.. 2020;Sepsis: Diagnosis and management. Am Fam Physician 101(7):409–418.
21. Park J.Y.. 1995;Laboratory diagnosis of sepsis. Pediatr Infect Vaccine 2(1):94–100.
22. Lee S.M., Choi S.H., Song A.N., Lee J.Y., Chae J., Jung E.H., et al. 2013;Case study of metastatic cholangiocarcinoma with sepsis who showed symptomatic improvement after treated with Handayeolso-tang, Fel Tauri, and antibiotics. J Sasang Constitut Med 25(4):432–441.
https://doi.org/10.7730/JSCM.2013.25.4.432
.
23. Yun Y.H., Son B.K., Yu S.M., Choi I.H.. 2009;A case of Atopic dermatitis with sepsis. J Korean Med Ophthalmol Otolaryngol Dermatol 22(3):237–245.
24. Yang J.S., Shin H.J., Lee C.H., Lee K.G., Kwon G.J., Woo W.H., et al. 2004;Effects of morphological changes and intestinal transit time after administration of Daesenggi-tang in rats. J Physiol & Pathol Korean Med 18(4):1199–1206.
26. Choi E.B., Kim Y.S.. 2008;Effect of Daeseungki-tang on apoptotic neuronal cell death of MCAO rats. J Physiol & Pathol Korean Med 22(2):403–409.
27. Oh J.H., Kim B.S., Lim H.Y., Kim D.W., Choi B.H., Kim D.J., et al. 2004;A case of stroke patient who showed improvement in constipation, chest discomfort and insomnia trough treatment of Daeseungkitang. Korean J Orient Int Med 25(2):307–313.
28. Kim S.J., Kim J.Y., Ryu C.G., Seo J.H., Kim J.N., Sung W.Y.. 2011;A case report of the delirium accompanied Wi syndrome during the treatment of pneumonia. J of Oriental Neuropsychiatry 22(2):71–83.
29. Ju Y.S.. 2013. Jeungbo Ungok Herbology Wanju: Wooseok. p. 576–584.
30. Rho E.J.. 2018. Gobangyuchwi Seoul: Barun Herbal Medicine. p. 448–465.
31. Jeon D.J., Cha Y.Y., Lee E.. 2011;Inflammatory effect of Rheum undulatum L. J Korean Med Rehabil 21(1):35–46.
32. Liu J.. 2017. Liu Jingyuan Onbyeonghak Lecture Paju: FishWood. p. 255.